Article citationsMore>>
T. K. Choueiri, U. N. Vaishampayan, J. E. Rosenberg, T. Logan, A. L. Harzstark, B. I. Rini, S. Srinivas, L. M. Adams, L. J. Sherham, L. H. Ottesen, D. F. McDermott, D. Bottaro, W. M. Linehan and R. Srinivasan, “A Phase II and Biomarker Study (MET 111644) of the Dual Met/VEGFR-2 Inhibitor Foretinib in Patients with Sporadic and Hereditary Papillary Renal Cell Carcinoma: Final Efficacy, Safety, and PD Results,” Journal of Clinical Oncology, Vol. 30, No. 5S, 2012, Abstract No. 355.
has been cited by the following article:
Related Articles:
-
S. Robinson, R. Nakkeeran
-
Frank T. D’Arcy, Ruth Foley, Thomas H. Lynch
-
Mudassar Iqbal, Anima Langer, Afroz Alam
-
Jai Dev Chandel, Nand Lal Singh
-
Mamadou Yaya Balde, Chantale Njiomou Djangang, Ramatoulaye Binta Diallo, Philippe Blanchart, Daniel Njopwouo